Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa británica busca experiencia en desarrollo de pruebas de diagnóstico para aplicación de sus compuestos fluorescentes

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRUK20170605001
Publicado:
06/06/2017
Caducidad:
06/06/2018
Resumen:
Una pyme británica ha desarrollado derivados intrínsecamente fluorescentes de moléculas retinoides de señalización celular. Los derivados presentan una fuerte fluorescencia intrínseca y retienen la actividad biológica de la molécula original. La empresa, que ha desarrollado estos compuestos para adquisición de imágenes de células, busca otras aplicaciones, por ejemplo, en el campo de pruebas de diagnóstico. La empresa busca compañías y centros de investigación especializados en desarrollo de pruebas o dispositivos de diagnóstico para estudiar otras aplicaciones. El objetivo es establecer acuerdos de joint venture, investigación o cooperación técnica.

Details

Tittle:
UK-based SME seeks diagnostic test development expertise to develop its novel fluorescent compounds for diagnostic applications.
Summary:
A UK-based SME has developed intrinsically fluorescent derivatives of retinoid cell signalling molecules. Having developed these compounds for cell imaging the company is looking at other applications including diagnostic testing. The SME is looking to partner with companies and research organisations experienced in developing diagnostic tests and / or devices to explore this application further. Partnerships are envisaged as joint ventures, research cooperations or technical cooperations.
Description:
Cell signalling molecules are involved in a wide variety of cell processes making them and their signalling pathways of interest for the diagnosis of diseases arising from changes in cell processes such as cancer. Retinoids are an important group of such cell signalling molecules.

A UK-based SME has developed a library of retinoid derivatives that exhibit strong intrinsic fluorescence, whilst retaining the biological activity of the original molecule. The company has had success in developing and using these compounds for cell imaging applications and is now looking at other potential uses of the technology. They are interested in exploring the potential of these compounds as an indicator agent in diagnostic medical devices with the focus on conditions associated with changes in cell processes regulated by retinoids, particularly proliferation, differentiation and apoptosis making cancer an obvious first choice target.

The SME is looking for companies or research organisation active in the development of new diagnostic tests and especially diagnostic devices to provide expertise for exploring the potential of the SME´s fluorescent retinoid derivatives as an active or reporter agent in diagnostic tests. It is envisaged that the partnership will take the form of a joint venture agreement, research cooperation agreement or a technical cooperation agreement.
Technical Specification or Expertise Sought:
Expertise in developing diagnostic tests and in particular the incorporation of these tests into diagnostic devices.

Experience of working with novel compounds and developing for different applications.

Knowledge of the medical and diagnostic devices regulatory requirements in different geographies and what is required for registration of a new test.

Partner sought

Type and Role of Partner Sought:
The UK SME is looking to partner with companies and research organisations that are working on the development of new diagnostic tests particularly in the field of cancer. Partners with experience of developing tests for diagnostic devices or devices themselves are particularly sought.
The UK SME will provide its library of fluorescent retinoid derivatives as well as its expertise on developing these derivatives in order to optimise and potentially develop new compounds for diagnostic tests. The company will work with a partner to explore the potential for the SME´s fluorescent retinoid derivatives to be used as the basis for diagnostic tests. It is envisaged that the partnership will take the form of a joint venture agreement, a research cooperation agreement or a technical cooperation agreement.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English